{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:40:28Z","timestamp":1775144428888,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pertussis is a highly contagious respiratory tract infection that affects all ages, though it is most severe in young infants. Adults, especially those with respiratory conditions or other chronic illnesses can also suffer serious consequences of pertussis. Pertussis vaccination is the best method of disease prevention in a lifetime. This behavioral study aimed to assess physicians\u2019 attitudes towards pertussis vaccination in adults and the importance of pertussis vaccination for disease prevention, especially in those with chronic illnesses, and to determine the impact of the COVID-19 pandemic on adult vaccination behaviors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between November 2022 and January 2023, physicians from the US, France, and Germany registered in an independent online database were contacted to participate in this study. After eligibility screening, participating physicians completed an online questionnaire addressing topics related to physician recommendations and vaccination behavior around pertussis in adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight hundred physicians participated in the study (US: 400; France: 200; Germany: 200). Physicians\u2019 attitudes towards pertussis vaccination in adults were broadly similar between the countries. Overall, 65% of physicians believed in the importance of vaccination against pertussis, a lower proportion than for COVID-19 (82%), influenza (81%), pneumococcal disease (76%), and tetanus (73%). Physicians considered immunocompromised adults or those with chronic obstructive pulmonary disease (COPD), asthma, or other respiratory conditions to be at greatest risk from pertussis. Physicians estimated that two-thirds of the adult patients to whom they recommended pertussis vaccination agreed to receive it. The top reason why they felt patients did not receive pertussis vaccination as recommended was low perception of personal risk for pertussis. Physicians\u2019 pertussis vaccination behavior was found to be similar before and after the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While physicians in the surveyed countries recognized the value of pertussis vaccination in adults, they ranked its importance lower than that of other adult vaccines. Physicians recognized the need to immunize vulnerable adults who are at risk of severe pertussis, such as those with asthma and\/or COPD, but this awareness frequently did not result in vaccination of these priority groups, especially without official recommendations to support such vaccination in these groups.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-024-02647-3","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:37:52Z","timestamp":1732613872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany"],"prefix":"10.1186","volume":"25","author":[{"given":"Donald","family":"Middleton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"2647_CR1","unstructured":"Centers for Disease Control and Prevention. Pertussis (Whooping Cough). https:\/\/www.cdc.gov\/pertussis\/index.html. Accessed 9 August 2023."},{"key":"2647_CR2","unstructured":"Centers for Disease Control and Prevention. The Pink Book. Chapter 16: Pertussis. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/pert.html. Accessed 9 August 2023."},{"key":"2647_CR3","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1093\/cid\/ciw550","volume":"63","author":"JD Cherry","year":"2016","unstructured":"Cherry JD. Pertussis in young infants throughout the world. Clin Infect Dis. 2016;63:S119\u201322.","journal-title":"Clin Infect Dis"},{"key":"2647_CR4","unstructured":"Centers for Disease Control and Prevention. Pertussis (Whooping Cough): Signs and Symptoms. https:\/\/www.cdc.gov\/pertussis\/about\/signs-symptoms.html. Accessed 9 August 2023."},{"key":"2647_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1086\/315648","volume":"182","author":"G De Serres","year":"2000","unstructured":"De Serres G, Shadmani R, Duval B, Boulianne N, D\u00e9ry P, Fradet MD, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174\u20139.","journal-title":"J Infect Dis"},{"key":"2647_CR6","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1017\/S0950268817000887","volume":"145","author":"PO Buck","year":"2017","unstructured":"Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017;145:2109\u201321.","journal-title":"Epidemiol Infect"},{"key":"2647_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","volume":"307","author":"KG Nicholson","year":"1993","unstructured":"Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982\u20136.","journal-title":"BMJ"},{"key":"2647_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/cid\/ciy889","volume":"69","author":"SA Mbayei","year":"2019","unstructured":"Mbayei SA, Faulkner A, Miner C, Edge K, Cruz V, Pe\u00f1a SA, et al. Severe pertussis infections in the United States, 2011\u20132015. Clin Infect Dis. 2019;69:218\u201326.","journal-title":"Clin Infect Dis"},{"key":"2647_CR9","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1080\/21645515.2020.1738168","volume":"16","author":"VA Jenkins","year":"2020","unstructured":"Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020;16:2609\u201317.","journal-title":"Hum Vaccin Immunother"},{"key":"2647_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s15010-005-4004-9","volume":"33","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, B\u00e4r G, Riffelmann M, Sol\u00e8r M, Heininger U. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection. 2005;33:13\u20137.","journal-title":"Infection"},{"key":"2647_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40121-023-00912-z","volume":"13","author":"B Surmann","year":"2024","unstructured":"Surmann B, Witte J, Batram M, Cri\u00e9e CP, Hermann C, Leischker A, et al. Epidemiology of pertussis and pertussis-related complications in adults: a German claims data analysis. Infect Dis Ther. 2024;13:385\u201399.","journal-title":"Infect Dis Ther"},{"key":"2647_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s40121-021-00465-z","volume":"10","author":"D Macina","year":"2021","unstructured":"Macina D, Evans KE. Pertussis in individuals with co-morbidities: a systematic review. Infect Dis Therapy. 2021;10:1141\u201370.","journal-title":"Infect Dis Therapy"},{"key":"2647_CR13","doi-asserted-by":"publisher","first-page":"q736","DOI":"10.1136\/bmj.q736","volume":"385","author":"E Smout","year":"2024","unstructured":"Smout E, Mellon D, Rae M. Whooping cough rises sharply in UK and Europe. BMJ. 2024;385:q736.","journal-title":"BMJ"},{"key":"2647_CR14","doi-asserted-by":"crossref","unstructured":"Khalil A, Samara A, Campbell H, Ladhani SN, Amirthalingam G. Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunizations: We must do better.now. Int J Infect Dis. 2024;146.","DOI":"10.1016\/j.ijid.2024.107148"},{"key":"2647_CR15","unstructured":"Centers for Disease Control and Prevention. About Diphtheria, Tetanus, and Pertussis Vaccines. https:\/\/www.cdc.gov\/vaccines\/vpd\/dtap-tdap-td\/hcp\/about-vaccine.html. Accessed 8 January 2024."},{"key":"2647_CR16","unstructured":"Centers for Disease Control and Prevention. What Vaccines are Recommended for You. https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/index.html. Accessed 3 April 2024."},{"key":"2647_CR17","unstructured":"Centers for Disease Control and Prevention: What You Need to Know About COPD, Asthma A, Vaccines. April. https:\/\/www.cdc.gov\/vaccines\/hcp\/adults\/downloads\/fs-asthma-vaccines.pdf. Accessed 3 2024."},{"key":"2647_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.socscimed.2016.04.030","volume":"159","author":"JL Moss","year":"2016","unstructured":"Moss JL, Reiter PL, Rimer BK, Brewer NT. Collaborative patient-provider communication and uptake of adolescent vaccines. Soc Sci Med. 2016;159:100\u20137.","journal-title":"Soc Sci Med"},{"key":"2647_CR19","unstructured":"Ordre National des Pharmaciens. Convention pharmaceutique: entr\u00e9e en application le 7 novembre des entretiens pour les femmes enceintes et de l\u2019administration des vaccins prescrits. https:\/\/www.ordre.pharmacien.fr\/les-communications\/focus-sur\/les-actualites\/convention-pharmaceutique-entree-en-application-le-7-novembre-des-entretiens-pour-les-femmes-enceintes-et-de-l-administration-des-vaccins-prescrits. Accessed 10 August 2023."},{"key":"2647_CR20","unstructured":"Centers for Disease Control and Prevention. Vaccination coverage among adults in the United States, National Health Interview Survey, 2019\u20132020. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2019-2020.html. Accessed 9 August 2023."},{"key":"2647_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imj.2022.12.002","volume":"2","author":"R Verdier","year":"2023","unstructured":"Verdier R, Marchal C, Belhassen M, Pannerer ML, Guiso N, Cohen R. Coverage rates for diphtheria, tetanus, Poliomyelitis, and pertussis age-specific booster recommendations in France: 2018 update of the real-world cohort analysis. Infect Med (Beijing). 2023;2:51\u20136.","journal-title":"Infect Med (Beijing)"},{"key":"2647_CR22","unstructured":"Robert Koch Institut. Epidemiologisches Bulletin 49\/2022. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2022\/Ausgaben\/49_22.pdf?__blob=publicationFile. Accessed 10 August 2023."},{"key":"2647_CR23","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.3390\/ijerph19074412","volume":"19","author":"G Gabutti","year":"2022","unstructured":"Gabutti G, Cetin I, Conversano M, Costantino C, Durando P, Giuffrida S. Experts\u2019 opinion for improving pertussis vaccination rates in adolescents and adults: a call to action. Int J Environ Res Public Health. 2022;19:4412.","journal-title":"Int J Environ Res Public Health"},{"key":"2647_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/21645515.2020.1756669","volume":"17","author":"A Kopp","year":"2021","unstructured":"Kopp A, Mangin O, Gantzer L, Lekens B, Simoneau G, Ravelomanantsoa M, et al. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease. Hum Vaccin Immunother. 2021;17:162\u20139.","journal-title":"Hum Vaccin Immunother"},{"key":"2647_CR25","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1016\/j.vaccine.2022.06.071","volume":"40","author":"B Wyplosz","year":"2022","unstructured":"Wyplosz B, Fernandes J, Sultan A, Roche N, Roubille F, Loubet P, et al. Pneumococcal and influenza vaccination coverage among at-risk adults: a 5-year French national observational study. Vaccine. 2022;40:4911\u201321.","journal-title":"Vaccine"},{"key":"2647_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pec.2010.08.005","volume":"85","author":"JK Bennett","year":"2011","unstructured":"Bennett JK, Fuertes JN, Keitel M, Phillips R. The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment. Patient Educ Couns. 2011;85:53\u20139.","journal-title":"Patient Educ Couns"},{"key":"2647_CR27","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2196\/jmir.5729","volume":"19","author":"SS-L Tan","year":"2017","unstructured":"Tan SS-L, Goonawardene N. Internet health information seeking and the patient-physician relationship: a systematic review. J Med Internet Res. 2017;19:e9.","journal-title":"J Med Internet Res"},{"key":"2647_CR28","doi-asserted-by":"publisher","unstructured":"Chipidza FE, Wallwork RS, Stern TA. Impact of the doctor-patient relationship. Prim Care Companion CNS Disord. 2015;17. https:\/\/doi.org\/10.4088\/PCC.15f01840.","DOI":"10.4088\/PCC.15f01840"},{"key":"2647_CR29","doi-asserted-by":"publisher","first-page":"e0261844","DOI":"10.1371\/journal.pone.0261844","volume":"16","author":"AJ Gallant","year":"2021","unstructured":"Gallant AJ, Nicholls LAB, Rasmussen S, Cogan N, Young D, Williams L. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: a longitudinal study of older adults in the UK. PLoS ONE. 2021;16:e0261844.","journal-title":"PLoS ONE"},{"key":"2647_CR30","doi-asserted-by":"crossref","unstructured":"Skyles TJ, Stevens HP, Obray AM, Jensen JL, Miner DS, Bodily RJ et al. Changes in attitudes and barriers to seasonal influenza vaccination from 2007 to 2023. J Community Health. 2023;Epub ahead of print.","DOI":"10.1007\/s10900-023-01277-7"},{"key":"2647_CR31","unstructured":"National Institute on Aging. Vaccinations and older adults: Tetanus, diphtheria, and pertussis (whooping cough) vaccines. https:\/\/www.nia.nih.gov\/health\/vaccinations-older-adults. Accessed 6 October 2023."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-024-02647-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T10:02:41Z","timestamp":1732615361000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-024-02647-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2647"],"URL":"https:\/\/doi.org\/10.1186\/s12875-024-02647-3","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human Ethics approval was not applicable. Informed consent was obtained from all participants. The study was carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DM has been an advisor on vaccines for Merck, GSK, Pfizer, Sanofi, CSL Seqirus, Novavax, Moderna, Dynavax, and Valneva. He has also been a speaker for CSL Seqirus, Pfizer, and Sanofi. LC is an employee at Sanofi.\u00a0AM declares the following relationships with the pharmaceutical industry as part of being an Open Rome employee, without any individual benefit: participation in influenza or vaccination advisory boards or lectures at meetings (Sanofi, Viatris, CSL Seqirus, IQVIA); and invitation to conferences (Sanofi). Besides this, she is a member of the influenza group of the French Microbiology Society (SFM).\u00a0UH declares receiving consulting fees for the Global Pertussis Initiative (Sanofi), the Central and Eastern Europe Pertussis Awareness Group (Sanofi), and for pertussis consultation (GSK). He received product-independent lectures fees from GSK, InfectoPharm, Merck, Moderna, Pfizer, Roche, and Sanofi. He also participated in the Data Monitoring Committees of a poliomyelitis vaccine (Takeda), a Phase II study of an adjuvanted pandemic influenza vaccine (GSK\/Watermark), the Norovirus Bivalent VLP Vaccine Program (Takeda\/HilleVax), and the Cell-based Quadrivalent Influenza Vaccine (Seqirus QIV). Ulrich Heininger sits on the Meta Data Safety Monitoring Board for the Coalition for Epidemic Preparedness Innovations and has been a member of the Varicella Advisory Board, Switzerland (Merck) for the period 2000\u20132022. Besides this, he was a member of St\u00e4ndige Impfkommission (Standing Committee on Vaccination) in Germany from 2001 until March 2024. He is currently the President of the Pediatric Infectious Disease Group of Switzerland and is a member and past Chair of the Committee for Infectious Diseases and Vaccines, B\u00fcndnis Kinder- und Jugendgesundheit (formerly the German Academy of Pediatrics), Germany (all without financial support).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}